Development of romiplostim for the treatment of patients with chronic immune thrombocytopenia: from bench to bedside.
about
Current Management of Primary Immune ThrombocytopeniaFc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeuticsDrugs derived from phage display: from candidate identification to clinical practiceEltrombopag modulates reactive oxygen species and decreases acute myeloid leukemia cell survivalPeptibodies: A flexible alternative format to antibodies.Treatment of 5 dogs with immune-mediated thrombocytopenia using RomiplostimSpotlight on romiplostim in the treatment of children with chronic immune thrombocytopenia: design, development, and potential place in therapy.Ligand-binding mass spectrometry to study biotransformation of fusion protein drugs and guide immunoassay development: strategic approach and application to peptibodies targeting the thrombopoietin receptor.Investigation of the mechanism of clearance of AMG 386, a selective angiopoietin-1/2 neutralizing peptibody, in splenectomized, nephrectomized, and FcRn knockout rodent models.Generation of new peptide-Fc fusion proteins that mediate antibody-dependent cellular cytotoxicity against different types of cancer cells.Access to site-specific Fc-cRGD peptide conjugates through streamlined expressed protein ligation.
P2860
Q26779408-F861F7E4-1B58-4F83-90F3-CE6B40B5A05FQ26822421-9118F0CE-DD7F-4D81-9040-5464EA9D2EAEQ27007101-90161393-AD7A-4C80-A2AE-BA006EEE8B6BQ28546734-0A2F10AE-D27E-4CA0-991D-16D7DF077DFDQ33402480-B0F7013A-200C-4544-A159-3E23890C1E1EQ33432920-A599B629-CC85-4E05-9976-7117C93CE773Q33440990-77FE171F-89F2-455F-9A51-A483A56A58D8Q33631378-388B3A77-1849-48BD-95F7-22F6604EF85FQ35813114-F87FA463-869D-4FE3-92F4-38D183FEE0C2Q41851061-2011E193-F513-4206-B465-DBECB55FD0DFQ48310799-F16E42F0-5250-4C4E-850F-724348CCFA0C
P2860
Development of romiplostim for the treatment of patients with chronic immune thrombocytopenia: from bench to bedside.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Development of romiplostim for ...... openia: from bench to bedside.
@ast
Development of romiplostim for ...... openia: from bench to bedside.
@en
type
label
Development of romiplostim for ...... openia: from bench to bedside.
@ast
Development of romiplostim for ...... openia: from bench to bedside.
@en
prefLabel
Development of romiplostim for ...... openia: from bench to bedside.
@ast
Development of romiplostim for ...... openia: from bench to bedside.
@en
P2860
P1476
Development of romiplostim for ...... openia: from bench to bedside.
@en
P2093
Adrian Newland
Graham Molineux
P2860
P356
10.1111/J.1365-2141.2010.08140.X
P407
P577
2010-03-17T00:00:00Z